US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

RENOVARO BIOSCIENCES INC

0.3482

-0.0535-13.32%

Post-market: 0.38770.0395+11.34%19:51 EDT

Volume:637.04K

Turnover:241.52K

Market Cap:55.74M

PE:-0.42

High:0.4479

Open:0.4122

Low:0.3412

Close:0.4017

Loading ...

Overview Company News Filings

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires Live

Top Midday Gainers

MT Newswires Live

BUZZ-Renovaro, Predictive Oncology soar after announcing merger plans

BRIEF-Predictive Oncology Announces Agreement To Be Acquired By Renovaro

BRIEF-Renovaro To Acquire Predictive Oncology In All-Stock Transaction

Renovaro Signs Letter of Intent to Acquire Predictive Oncology via All-Stock Deal

MT Newswires Live

Predictive Oncology in Deal to Be Sold to Renovaro

Renovaro to acquire Predictive Oncology in all-stock transaction

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Predictive Oncology Inc - Renovaro Can Redeem Preferred Stock for $3.00 per Share

THOMSON REUTERS

Predictive Oncology Announces Agreement to Be Acquired by Renovaro

THOMSON REUTERS

Predictive Oncology Inc - Merger Expected to Reduce Operating Expenses by Over 30%

THOMSON REUTERS

Predictive Oncology Inc - Preferred Stock Issued in 1:1 Exchange for Predictive Oncology Common Stock

THOMSON REUTERS

Predictive Oncology Announces Agreement to be Acquired by Renovaro

Press Release: Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Renovaro Inc: Received Grant Funding Approval for Lumina Project From Eurostars Funding Program

THOMSON REUTERS

Press Release: RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Renovaro Regains Compliance With Nasdaq Listing Rule

MT Newswires Live

Renovaro Regains Compliance with NASDAQ Listing Requirement

Renovaro Shares Rise After Launching Collaboration With Nebul Focused on Early Disease Detection

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RENB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RENB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RENB\",,,,,undefined,":{"symbol":"RENB","market":"US","secType":"STK","nameCN":"RENOVARO BIOSCIENCES INC","latestPrice":0.3482,"timestamp":1745352000000,"preClose":0.4017,"halted":0,"volume":637036,"hourTrading":{"tag":"盘后","latestPrice":0.3877,"preClose":0.3482,"latestTime":"19:51 EDT","volume":5801,"amount":2211.5758,"timestamp":1745365866065},"delay":0,"floatShares":78893422,"shares":160086097,"eps":-0.821613,"marketStatus":"Closed","change":-0.0535,"latestTime":"04-22 16:00:00 EDT","open":0.4122,"high":0.4479,"low":0.3412,"amount":241524.75881951998,"amplitude":0.265621,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.821613,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4017,"preHourTrading":{"tag":"盘前","latestPrice":0.4,"preClose":0.4017,"latestTime":"09:29 EDT","volume":6800,"amount":2801.52248,"timestamp":1745328567727},"postHourTrading":{"tag":"盘后","latestPrice":0.3877,"preClose":0.3482,"latestTime":"19:51 EDT","volume":5801,"amount":2211.5758,"timestamp":1745365866065},"volumeRatio":1.062505,"impliedVol":0.3452,"impliedVolPercentile":0.088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RENB\",,,,,undefined,":{"symbol":"RENB","floatShares":78893422,"roa":"-18.09%","roe":"-188.47%","lyrEps":-0.83794,"volumeRatio":1.062505,"shares":160086097,"dividePrice":0,"high":0.4479,"amplitude":0.265621,"preClose":0.4017,"low":0.3412,"week52Low":0.3214,"pbRate":"0.68","week52High":2.34,"institutionHeld":0,"latestPrice":0.3482,"eps":-0.821613,"divideRate":0,"volume":637036,"delay":0,"ttmEps":-0.821613,"open":0.4122,"prevYearClose":0.8355,"prevWeekClose":0.3526,"prevMonthClose":0.5432,"prevQuarterClose":0.5432,"fiveDayClose":0.3585,"twentyDayClose":0.7185,"sixtyDayClose":0.8906},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RENB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2501267825","title":"Sector Update: Health Care Stocks Decline Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2501267825","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501267825?lang=en_us&edition=fundamental","pubTime":"2025-01-07 05:02","pubTimestamp":1736197371,"startTime":"0","endTime":"0","summary":"Health care stocks were lower late Monday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund  easing 0.1%.The iShares Biotechnology ETF  added 0.1%.In corporate news, Predictive Oncology  shares surged past 55% after it agreed to be acquired by Renovaro  in an all-stock deal. Renovaro shares popped 10%.Citius Pharmaceuticals'  majority-owned subsidiary Citius Oncology  said it has retained Jefferies as a financial advisor to evaluate possible strategic alternatives. Citius Pharmaceuticals shares were down 2.3% and Citius Oncology jumped 18%.Revance Therapeutics  shares jumped 12%. The company has received a new buyout proposal from Teoxane Laboratories, offering $3.60 per share in cash, topping a bid from Crown Laboratories of $3.10 per share.Regional Health Properties  and SunLink Health Systems  have agreed to merge in an all-stock deal. Regional shares soared 120% and SunLink surged 16%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4185","BK4007","BK4198","CTOR","BK4581","BK4585","IBB","POAI","RENB","CTXR","LU0053671581.USD","RVNC","SSY","RHE","XLV","BK4588","BK4139","BK4082"],"gpt_icon":0},{"id":"2501266173","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2501266173","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501266173?lang=en_us&edition=fundamental","pubTime":"2025-01-07 03:04","pubTimestamp":1736190277,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC) announced the publication of a European patent application that its collaboration partner Clearmind Medicine (CMND) submitted with the European Patent Office for a binge behavior psych","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4108","SG9999015945.SGD","BK4507","LU0011850046.USD","LU0061475181.USD","LU0640476718.USD","BK4581","BK4139","LU0029864427.USD","BK4554","BK4585","SG9999015952.SGD","LU0786609619.USD","LU0208291251.USD","SG9999015986.USD","BK4588","LU0708994859.HKD","LU0310800379.SGD","FUBO","POAI","BK4534","LU1280957306.USD","RENB","BK4077","BK4198","BK4561","CMND","LU0320765489.SGD","SG9999015978.USD","GB00BDT5M118.USD","LU0128525929.USD","BK4524","LU1267930573.SGD","BK4007","LU1894683264.USD","LU1894683348.USD","BK4550","SPRC","BK4598","BK4551","BK4082","DIS","LU0070302665.USD","BK4532"],"gpt_icon":1},{"id":"2501251331","title":"BUZZ-Renovaro, Predictive Oncology soar after announcing merger plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2501251331","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501251331?lang=en_us&edition=fundamental","pubTime":"2025-01-06 23:58","pubTimestamp":1736179109,"startTime":"0","endTime":"0","summary":"** Shares of biotech company Renovaro    up as much as 38.2% to $1.28 after announcing plans to acquire cancer therapy developer Predictive Oncology    in an all-stock transaction   ** Shares of Predictive Oncology surged as much as 58% to $1.90   ** Both companies entered into a letter of intent for POAI to merge into RENB in exchange for a newly created preferred stock    ** Each preferred stock will be issued to POAI shareholders for their existing share, according to the deal terms   ** Deal also states that preferred stock is redeemable for $3 per share after 18 months, or can be converted to Renovaro common stock if RENB trades above $4.50 per share for 30 consecutive trading days   ** Both companies agreed to enter into definitive documentation for the merger by Feb. 28, 2025, with deal being subject to the fundraising of $15 mln by Renovaro and formal approval by POAI shareholders   ** POAI had announced its intent to explore strategic alternatives including a sale on Nov. 13  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","POAI","BK4139","BK4198","BK4082"],"gpt_icon":0},{"id":"2501584102","title":"BRIEF-Predictive Oncology Announces Agreement To Be Acquired By Renovaro","url":"https://stock-news.laohu8.com/highlight/detail?id=2501584102","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501584102?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:50","pubTimestamp":1736175030,"startTime":"0","endTime":"0","summary":"Jan 6  - Predictive Oncology Inc   :   * PREDICTIVE ONCOLOGY ANNOUNCES AGREEMENT TO BE ACQUIRED BY RENOVARO   * PREDICTIVE ONCOLOGY INC - MERGER EXPECTED TO REDUCE OPERATING EXPENSES BY OVER 30%   * PREDICTIVE ONCOLOGY INC - PREFERRED STOCK ISSUED IN 1:1 EXCHANGE FOR PREDICTIVE ONCOLOGY COMMON STOCK   * PREDICTIVE ONCOLOGY INC - RENOVARO CAN REDEEM PREFERRED STOCK FOR $3.00 PER SHARESource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","RENB","POAI","BK4198"],"gpt_icon":0},{"id":"2501581522","title":"BRIEF-Renovaro To Acquire Predictive Oncology In All-Stock Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2501581522","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501581522?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:49","pubTimestamp":1736174988,"startTime":"0","endTime":"0","summary":"BRIEF-Renovaro To Acquire Predictive Oncology In All-Stock TransactionJan 6 (Reuters) - Renovaro RENB.O:RENOVARO TO ACQUIRE PREDICTIVE ONCOLOGY IN ALL-STOCK TRANSACTIONSource text: ID:nGNX1d66FHFurther company coverage: RENB.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA3LCVRK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2501581042","title":"Renovaro Signs Letter of Intent to Acquire Predictive Oncology via All-Stock Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2501581042","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501581042?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:48","pubTimestamp":1736174895,"startTime":"0","endTime":"0","summary":"Renovaro  signed a binding letter of intent to acquire Predictive Oncology , the companies said Monday.Under the terms of the agreement, Predictive Oncology will merge into Renovaro in exchange for a newly created series of Renovaro preferred stock, Predictive Oncology said.The company said the parties are looking to enter definitive documentation for the merger by no later than Feb. 28.Renovaro shares were up 12% while POAI shares were due off halt at 9:50 am ET.Price: 1.21, Change: +0.28, Percent Change: +30.13","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","POAI","BK4198","BK4139","RENB"],"gpt_icon":0},{"id":"2501230828","title":"Predictive Oncology in Deal to Be Sold to Renovaro","url":"https://stock-news.laohu8.com/highlight/detail?id=2501230828","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501230828?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:22","pubTimestamp":1736173320,"startTime":"0","endTime":"0","summary":"Predictive Oncology has signed a deal to be taken over by Renovaro in exchange for a newly created series of preferred stock in the biotechnology company.The AI-driven drug-discovery company on Monday said that the acquisition, which follows a formal review of strategic alternatives put in place since mid-November, would reduce its operating expenses by more than 30% on a combined basis in the near term.The acquisition is subject to a minimum fundraising of $15 million by Renovaro, as well as formal approval by Predictive Oncology's shareholders.There is no assurance that an agreement or transaction with Renovaro will be executed.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4198","POAI","BK4082","RENB"],"gpt_icon":0},{"id":"2501230758","title":"Renovaro to acquire Predictive Oncology in all-stock transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2501230758","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501230758?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:20","pubTimestamp":1736173252,"startTime":"0","endTime":"0","summary":"Renovaro (RENB) announced it has entered into a binding LOI to acquire Predictive Oncology (POAI) in an all-stock transaction.By leveraging Predict...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovaro-to-acquire-predictive-oncology-in-all-stock-transaction?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovaro-to-acquire-predictive-oncology-in-all-stock-transaction?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RENB","BK4198","BK4139","BK4082","POAI"],"gpt_icon":0},{"id":"2501237035","title":"Renovaro to Acquire Predictive Oncology in All-Stock Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2501237035","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501237035?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:15","pubTimestamp":1736172900,"startTime":"0","endTime":"0","summary":"Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and decades of longitudinal drug response data Data provides a c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/06/3004710/0/en/Renovaro-to-Acquire-Predictive-Oncology-in-All-Stock-Transaction.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POAI","BK4082","BK4139","BK4198","RENB"],"gpt_icon":0},{"id":"2501376492","title":"Predictive Oncology Inc - Renovaro Can Redeem Preferred Stock for $3.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2501376492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501376492?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:10","pubTimestamp":1736172600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA54Y42X:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","POAI","BK4082","BK4139","RENB"],"gpt_icon":0},{"id":"2501237647","title":"Predictive Oncology Announces Agreement to Be Acquired by Renovaro","url":"https://stock-news.laohu8.com/highlight/detail?id=2501237647","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501237647?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:10","pubTimestamp":1736172600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA54Y42X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4198","BK4139","BK4082","POAI"],"gpt_icon":0},{"id":"2501237640","title":"Predictive Oncology Inc - Merger Expected to Reduce Operating Expenses by Over 30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501237640","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501237640?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:10","pubTimestamp":1736172600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA54Y42X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4139","BK4082","POAI","BK4198"],"gpt_icon":0},{"id":"2501223764","title":"Predictive Oncology Inc - Preferred Stock Issued in 1:1 Exchange for Predictive Oncology Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2501223764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501223764?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:10","pubTimestamp":1736172600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA54Y42X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4139","BK4082","POAI","BK4198"],"gpt_icon":0},{"id":"2501376022","title":"Predictive Oncology Announces Agreement to be Acquired by Renovaro","url":"https://stock-news.laohu8.com/highlight/detail?id=2501376022","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501376022?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:10","pubTimestamp":1736172600,"startTime":"0","endTime":"0","summary":"- Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple cancer indications –。- Deal terms align shareholders’ interest, augment business development opportunities and positioning in the capital markets -. Predictive and Renovaro share an unwavering commitment to improving outcomes of cancer patients through earlier diagnosis, biomarker discovery and targeted therapies. Further, the companies have proprietary AI / ML platforms with complementary technical advantages that will be leveraged together to accelerate drug discovery and reduce the risk of drug development. Beyond the scientific synergies, the merger presents an opportunity to recognize significant cost savings by reducing operating expenses by more than 30% on a combined basis in the near term.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/predictive-oncology-announces-agreement-acquired-141000010.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["POAI","BK4139","RENB","BK4082","BK4198"],"gpt_icon":0},{"id":"2495472005","title":"Press Release: Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV","url":"https://stock-news.laohu8.com/highlight/detail?id=2495472005","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495472005?lang=en_us&edition=fundamental","pubTime":"2024-12-30 22:00","pubTimestamp":1735567200,"startTime":"0","endTime":"0","summary":"Current Renovaro Chairman to Lead Subsidiary's Development Program and Commercialization. LOS ANGELES and AMSTERDAM, Dec. 30, 2024  -- Renovaro Inc. , a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced Chairman of the Board, Maurice van Tilburg, has been appointed as Chief Executive Officer of its subsidiary GEDi Cube BV  DBA RenovaroCube.\"I am thrilled to have the opportunity to lead GEDi Cube BV into its next exciting phase of development,\" said Maurice van Tilburg \"I believe that the transformative AI Cube platform will be an inflection point in the creation of diagnostics for early-stage cancer and identifying new genes for our Cancer Vaccine Platform. I look forward to working closely with the GEDiCube executive team to harness the power of multi-omics biomarkers and AI-driven technology with","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4120","RENB","BV"],"gpt_icon":0},{"id":"2493768772","title":"Renovaro Inc: Received Grant Funding Approval for Lumina Project From Eurostars Funding Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2493768772","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493768772?lang=en_us&edition=fundamental","pubTime":"2024-12-23 22:03","pubTimestamp":1734962616,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nFWN3NO0HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2493768268","title":"Press Release: RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2493768268","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493768268?lang=en_us&edition=fundamental","pubTime":"2024-12-23 22:00","pubTimestamp":1734962400,"startTime":"0","endTime":"0","summary":"LUMINA is an Advanced Minimal Residual Disease Detection Platform for Lung Cancer Harnessing the Power of Multi-omics Biomarkers and AI. \"This award further validates our purpose-built AI platform in facilitating the discovery of biomarkers critical for early cancer detection, monitoring, and treatment personalization,\" said David Weinstein, Chief Executive Officer of Renovaro. \"In partnership with leading institutions and companies, including Uppsala University, Oncodia AB, and Flomics Biotech, the Lumina project is focused on improving lung cancer patient survival. Over 5.7 million lung cancer cases are treated or monitored globally each year, and of all curatively treated lung cancer patients, 60% will relapse. Lumina represents a significant opportunity to address this critical issue, and we look forward to continuing work with our partners to bring this product to market.\". The LUMINA project is built on a strong foundation of collaboration with leading institutions and companies,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB","BK4179","NGS"],"gpt_icon":0},{"id":"2493479479","title":"Renovaro Regains Compliance With Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2493479479","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493479479?lang=en_us&edition=fundamental","pubTime":"2024-12-21 04:55","pubTimestamp":1734728132,"startTime":"0","endTime":"0","summary":"Renovaro (RENB) said Friday it regained compliance with Nasdaq's minimum bid price requirement.Shares of Renovaro rose 7.1% in recent Friday trading.Price: 1.66, Change: +0.11, Percent Change: +7.12","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IE00B64PRP62.GBP","SQQQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","QID","BK4588","NVIW.SI","NQmain","BK4112","USAW.SI","BK4139","QLD",".IXIC","NDAQ","TSYW.SI","LU2210150020.SGD","LU2095319765.USD","RENB","MNQmain","LU2210149790.SGD","USJW.SI","PSQ","IE00BGHQF748.EUR","TQQQ"],"gpt_icon":0},{"id":"2493479651","title":"Renovaro Regains Compliance with NASDAQ Listing Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2493479651","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493479651?lang=en_us&edition=fundamental","pubTime":"2024-12-21 04:40","pubTimestamp":1734727200,"startTime":"0","endTime":"0","summary":"LOS ANGELES, Dec.  20, 2024  (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced that it has received","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/20/3000837/0/en/Renovaro-Regains-Compliance-with-NASDAQ-Listing-Requirement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","QLD","NVIW.SI","LU2095319765.USD","USJW.SI","MNQmain","IE00B3QW5Z07.USD","NQmain","BK4588","TQQQ","BK4112","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","LU2210150020.SGD","TSYW.SI","NDAQ","BK4139","QID","RENB","IE00BKPKM429.USD","IE00BGHQF748.EUR","USAW.SI","PSQ",".IXIC"],"gpt_icon":1},{"id":"2492442858","title":"Renovaro Shares Rise After Launching Collaboration With Nebul Focused on Early Disease Detection","url":"https://stock-news.laohu8.com/highlight/detail?id=2492442858","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492442858?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:58","pubTimestamp":1734706737,"startTime":"0","endTime":"0","summary":"Renovaro  shares rose 8.4% in recent Friday trading after the company said its Renovaro Cube unit has launched a collaboration with artificial intelligence cloud infrastructure company Nebul to back projects for the early detection of cancer and other diseases.Financial details weren't provided.The project will use AI technologies and high-performance computing to \"transform diagnostic and therapeutic methodologies,\" Renovaro said.\"The potential for multi-cancer early detection screening and recurrence testing will be powered by AI chips that can process vast data sets,\" Renovaro Chief Executive David Weinstein said in a statement.Price: 1.68, Change: +0.13, Percent Change: +8.41","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RENB","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RENB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-19","symbol":"RENB","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2024-11-14","symbol":"RENB","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2024-10-10","symbol":"RENB","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1728532800000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2024-05-15","symbol":"RENB","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2024-02-14","symbol":"RENB","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707886800000,"reportTimeType":"post","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RENB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RENB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RENB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RENB","date":"2025-04-21","current":-0.476701,"percent":0.997512,"low":-11.254936,"twenty":-6.927186,"median":-2.162652,"eighty":-1.030478,"high":-0.427977,"avg":-3.594354,"sd":2.943931,"marketCap":56446357},"quantilePoints":[{"date":"2023-08-11","current":-0.842296,"twenty":-0.858231,"median":-0.663023,"eighty":-0.461441,"marketCap":89892200},{"date":"2023-08-18","current":-0.921973,"twenty":-0.901484,"median":-0.882134,"eighty":-0.681804,"marketCap":98395516},{"date":"2023-08-25","current":-1.38865,"twenty":-1.080188,"median":-0.904899,"eighty":-0.830914,"marketCap":148200654},{"date":"2023-09-01","current":-1.781342,"twenty":-1.390926,"median":-1.024414,"eighty":-0.866199,"marketCap":190109855},{"date":"2023-09-08","current":-1.838254,"twenty":-1.738089,"median":-1.138238,"eighty":-0.882134,"marketCap":196183652},{"date":"2023-09-15","current":-1.804107,"twenty":-1.831424,"median":-1.371576,"eighty":-0.88441,"marketCap":192539374},{"date":"2023-09-22","current":-2.191108,"twenty":-1.848498,"median":-1.479709,"eighty":-0.901484,"marketCap":233841196},{"date":"2023-09-29","current":-2.316314,"twenty":-1.946387,"median":-1.676055,"eighty":-0.933355,"marketCap":247203550},{"date":"2023-10-06","current":-7.118779,"twenty":-2.179726,"median":-1.781342,"eighty":-0.980023,"marketCap":282502019},{"date":"2023-10-13","current":-7.74788,"twenty":-5.197793,"median":-1.82118,"eighty":-1.031244,"marketCap":307467313},{"date":"2023-10-20","current":-5.711578,"twenty":-7.168445,"median":-1.855328,"eighty":-1.080188,"marketCap":226658596},{"date":"2023-10-27","current":-4.635484,"twenty":-7.135334,"median":-1.855328,"eighty":-1.118888,"marketCap":183954803},{"date":"2023-11-03","current":-5.049366,"twenty":-7.026069,"median":-1.943541,"eighty":-1.206532,"marketCap":200379339},{"date":"2023-11-10","current":-4.689234,"twenty":-6.615498,"median":-2.10574,"eighty":-1.302144,"marketCap":186087821},{"date":"2023-11-17","current":-4.561671,"twenty":-5.969841,"median":-2.191108,"eighty":-1.374991,"marketCap":187755275},{"date":"2023-11-24","current":-5.396221,"twenty":-5.585435,"median":-2.219564,"eighty":-1.390926,"marketCap":222104819},{"date":"2023-12-01","current":-5.396221,"twenty":-5.49345,"median":-4.524078,"eighty":-1.428488,"marketCap":222104819},{"date":"2023-12-08","current":-5.444836,"twenty":-5.444836,"median":-4.635484,"eighty":-1.545727,"marketCap":224105763},{"date":"2023-12-15","current":-5.720319,"twenty":-5.636053,"median":-4.686221,"eighty":-1.656136,"marketCap":235444448},{"date":"2023-12-22","current":-5.412426,"twenty":-5.636053,"median":-4.701705,"eighty":-1.675486,"marketCap":222771800},{"date":"2023-12-29","current":-5.169353,"twenty":-5.606885,"median":-4.76643,"eighty":-1.678901,"marketCap":212767079},{"date":"2024-01-05","current":-5.847089,"twenty":-5.626331,"median":-4.823692,"eighty":-1.699389,"marketCap":240662238},{"date":"2024-01-12","current":-7.088371,"twenty":-5.780749,"median":-4.953966,"eighty":-1.754024,"marketCap":291752546},{"date":"2024-01-19","current":-7.349693,"twenty":-6.206408,"median":-5.070988,"eighty":-1.790448,"marketCap":302508400},{"date":"2024-01-26","current":-7.962168,"twenty":-7.106616,"median":-5.169353,"eighty":-1.810936,"marketCap":327717433},{"date":"2024-02-02","current":-7.072038,"twenty":-7.137369,"median":-5.263632,"eighty":-1.82118,"marketCap":291080305},{"date":"2024-02-09","current":-5.896087,"twenty":-7.137369,"median":-5.347607,"eighty":-1.82801,"marketCap":242678961},{"date":"2024-02-16","current":-6.969,"twenty":-7.137369,"median":-5.363812,"eighty":-1.845084,"marketCap":287336744},{"date":"2024-02-23","current":-6.969,"twenty":-7.150435,"median":-5.387578,"eighty":-1.855328,"marketCap":287336744},{"date":"2024-03-01","current":-8.990011,"twenty":-7.198517,"median":-5.396221,"eighty":-1.861019,"marketCap":370664399},{"date":"2024-03-08","current":-10.418656,"twenty":-7.379651,"median":-5.404324,"eighty":-1.89289,"marketCap":429568432},{"date":"2024-03-15","current":-10.906486,"twenty":-7.477571,"median":-5.444836,"eighty":-1.935004,"marketCap":449682004},{"date":"2024-03-22","current":-10.244431,"twenty":-7.594683,"median":-5.466304,"eighty":-1.975981,"marketCap":422385013},{"date":"2024-03-28","current":-9.721756,"twenty":-7.6659,"median":-5.49345,"eighty":-2.048828,"marketCap":400834757},{"date":"2024-04-05","current":-9.721756,"twenty":-7.780991,"median":-5.585767,"eighty":-2.162652,"marketCap":400834757},{"date":"2024-04-12","current":-8.537025,"twenty":-7.909815,"median":-5.683539,"eighty":-2.162652,"marketCap":351987511},{"date":"2024-04-19","current":-8.01435,"twenty":-8.049195,"median":-5.736523,"eighty":-2.191108,"marketCap":330437255},{"date":"2024-04-26","current":-5.92365,"twenty":-8.01435,"median":-5.889227,"eighty":-2.196799,"marketCap":244236232},{"date":"2024-05-03","current":-5.191905,"twenty":-7.962168,"median":-5.736523,"eighty":-2.219564,"marketCap":214065874},{"date":"2024-05-10","current":-4.1814,"twenty":-7.909815,"median":-5.683539,"eighty":-2.316314,"marketCap":172402046},{"date":"2024-05-17","current":-2.443812,"twenty":-7.872338,"median":-5.585767,"eighty":-2.443812,"marketCap":131786997},{"date":"2024-05-24","current":-3.61057,"twenty":-7.790675,"median":-5.49948,"eighty":-2.523736,"marketCap":194706526},{"date":"2024-05-31","current":-4.020862,"twenty":-7.782928,"median":-5.490611,"eighty":-2.561678,"marketCap":216832267},{"date":"2024-06-07","current":-3.637923,"twenty":-7.780991,"median":-5.444836,"eighty":-2.581602,"marketCap":196181575},{"date":"2024-06-14","current":-3.966156,"twenty":-7.761124,"median":-5.43582,"eighty":-2.609206,"marketCap":213882168},{"date":"2024-06-21","current":-3.938803,"twenty":-7.742964,"median":-5.412426,"eighty":-2.63681,"marketCap":212407119},{"date":"2024-06-28","current":-4.10292,"twenty":-7.738048,"median":-5.396221,"eighty":-2.647751,"marketCap":221257416},{"date":"2024-07-05","current":-4.321743,"twenty":-7.714683,"median":-5.396221,"eighty":-2.94281,"marketCap":233057811},{"date":"2024-07-12","current":-3.966156,"twenty":-7.699226,"median":-5.387578,"eighty":-3.371454,"marketCap":213882168},{"date":"2024-07-15","current":-3.966156,"twenty":-7.69872,"median":-5.380016,"eighty":-3.449983,"marketCap":213882168},{"date":"2024-08-02","current":-1.91497,"twenty":-7.698214,"median":-5.371914,"eighty":-3.135869,"marketCap":103268211},{"date":"2024-08-09","current":-1.773009,"twenty":-7.6659,"median":-5.347607,"eighty":-2.571163,"marketCap":95612704},{"date":"2024-08-16","current":-1.858076,"twenty":-7.631055,"median":-5.298934,"eighty":-2.219564,"marketCap":100200108},{"date":"2024-08-23","current":-1.800361,"twenty":-7.615438,"median":-5.234173,"eighty":-2.162652,"marketCap":97087754},{"date":"2024-08-30","current":-1.096953,"twenty":-7.594683,"median":-5.191905,"eighty":-1.942322,"marketCap":96659989},{"date":"2024-09-06","current":-0.956172,"twenty":-7.594683,"median":-5.169353,"eighty":-1.883292,"marketCap":84254824},{"date":"2024-09-13","current":-1.039201,"twenty":-7.568029,"median":-5.122215,"eighty":-1.855328,"marketCap":91571069},{"date":"2024-09-20","current":-0.898922,"twenty":-7.561365,"median":-5.068368,"eighty":-1.82118,"marketCap":79210154},{"date":"2024-09-27","current":-0.801832,"twenty":-7.538402,"median":-4.941343,"eighty":-1.780605,"marketCap":70654868},{"date":"2024-10-04","current":-0.840501,"twenty":-7.499872,"median":-4.812365,"eighty":-1.72119,"marketCap":74062232},{"date":"2024-10-11","current":-0.852916,"twenty":-7.482618,"median":-4.731822,"eighty":-1.672382,"marketCap":68787798},{"date":"2024-10-18","current":-1.441668,"twenty":-7.469223,"median":-4.689234,"eighty":-1.611745,"marketCap":116270748},{"date":"2024-10-25","current":-0.987903,"twenty":-7.425307,"median":-4.683207,"eighty":-1.393203,"marketCap":79674514},{"date":"2024-10-31","current":-1.045809,"twenty":-7.406141,"median":-4.602373,"eighty":-1.33948,"marketCap":84344712},{"date":"2024-11-08","current":-1.091709,"twenty":-7.392372,"median":-4.486173,"eighty":-1.206786,"marketCap":88046508},{"date":"2024-11-15","current":-0.800809,"twenty":-7.364672,"median":-4.349095,"eighty":-1.204333,"marketCap":92643312},{"date":"2024-11-22","current":-0.687074,"twenty":-7.320294,"median":-4.29439,"eighty":-1.148518,"marketCap":79485644},{"date":"2024-11-29","current":-1.037745,"twenty":-7.274563,"median":-4.196865,"eighty":-1.139226,"marketCap":120053797},{"date":"2024-12-06","current":-1.975612,"twenty":-7.221841,"median":-4.130273,"eighty":-1.130296,"marketCap":228552972},{"date":"2024-12-13","current":-2.359759,"twenty":-7.19548,"median":-4.075567,"eighty":-1.139226,"marketCap":272993828},{"date":"2024-12-20","current":-2.119667,"twenty":-7.179834,"median":-4.020862,"eighty":-1.141284,"marketCap":245218293},{"date":"2024-12-27","current":-1.243675,"twenty":-7.166767,"median":-4.020862,"eighty":-1.14292,"marketCap":143877270},{"date":"2025-01-03","current":-1.046937,"twenty":-7.153701,"median":-3.966156,"eighty":-1.14215,"marketCap":121117203},{"date":"2025-01-10","current":-1.144209,"twenty":-7.140635,"median":-3.966156,"eighty":-1.143797,"marketCap":132370263},{"date":"2025-01-17","current":-1.028965,"twenty":-7.137369,"median":-3.938144,"eighty":-1.135591,"marketCap":119038006},{"date":"2025-01-24","current":-1.426831,"twenty":-7.127569,"median":-3.911451,"eighty":-1.121942,"marketCap":165066035},{"date":"2025-01-31","current":-1.049818,"twenty":-7.119682,"median":-3.884098,"eighty":-1.119209,"marketCap":121450510},{"date":"2025-02-07","current":-0.921952,"twenty":-7.100534,"median":-3.630902,"eighty":-1.092825,"marketCap":106658053},{"date":"2025-02-14","current":-1.017989,"twenty":-7.088371,"median":-3.528511,"eighty":-1.069204,"marketCap":117768267},{"date":"2025-02-21","current":-1.135052,"twenty":-7.081838,"median":-2.653222,"eighty":-1.076928,"marketCap":134401986},{"date":"2025-02-28","current":-1.347103,"twenty":-7.065505,"median":-2.598891,"eighty":-1.076928,"marketCap":159511096},{"date":"2025-03-07","current":-1.131299,"twenty":-7.048899,"median":-2.565552,"eighty":-1.088965,"marketCap":133957577},{"date":"2025-03-14","current":-1.060525,"twenty":-7.03869,"median":-2.436084,"eighty":-1.088965,"marketCap":125577293},{"date":"2025-03-21","current":-0.927155,"twenty":-7.03869,"median":-2.359759,"eighty":-1.067398,"marketCap":109784900},{"date":"2025-03-28","current":-0.870591,"twenty":-7.024371,"median":-2.291162,"eighty":-1.047047,"marketCap":103087022},{"date":"2025-04-04","current":-0.635556,"twenty":-6.989335,"median":-2.250002,"eighty":-1.040362,"marketCap":75256474},{"date":"2025-04-11","current":-0.49022,"twenty":-6.969,"median":-2.193954,"eighty":-1.037745,"marketCap":58047218},{"date":"2025-04-17","current":-0.486705,"twenty":-6.948093,"median":-2.165169,"eighty":-1.032556,"marketCap":57630994},{"date":"2025-04-21","current":-0.476701,"twenty":-6.927186,"median":-2.162652,"eighty":-1.030478,"marketCap":56446357}],"updateTime":1745370736040}}}